# FDA Inspection 1305486 - GlaxoSmithKline Biologicals SA - February 27, 2026

Source: https://www.keypedia.com/records/fda_inspections/glaxosmithkline-biologicals-sa/a73f4473-48f2-4d60-ada1-1284eeb61f46
Source feed: FDA_Inspections

> FDA Inspection 1305486 for GlaxoSmithKline Biologicals SA on February 27, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1305486
- Company Name: GlaxoSmithKline Biologicals SA
- Inspection Date: 2026-02-27
- Project Area: Vaccine, Allergenic, and Live Biotherapeutic Products
- Product Type: Biologics
- Office Name: Office of Inspections and Investigations

Company: https://www.keypedia.com/companies/glaxosmithkline-biologicals-sa/9a234513-4162-49b8-b149-5c1be5aa9090

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8